Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/Listing on record | Sell | $12.3K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | Sell | $63.8K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | Sell | $8.4K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | Buy | $40K | conv 65ClusterFirst in 12mo | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | Buy | $40K | conv 65ClusterFirst in 12mo | SEC |